Your browser doesn't support javascript.
loading
The influence of efavirenz on the pharmacokinetics of a twice-daily combination of indinavir and low-dose ritonavir in healthy volunteers.
Aarnoutse, Rob E; Grintjes, Karin J T; Telgt, Denise S C; Stek, Michael; Hugen, Patricia W H; Reiss, Peter; Koopmans, Peter P; Hekster, Yechiel A; Burger, David M.
Affiliation
  • Aarnoutse RE; Department of Clinical Pharmacy, University Medical Centre, Nijmegen, The Netherlands. R.Arnoutse@klinfarm.azn.nl
Clin Pharmacol Ther ; 71(1): 57-67, 2002 Jan.
Article in En | MEDLINE | ID: mdl-11823758
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Oxazines / HIV Protease Inhibitors / Indinavir / Ritonavir / Anti-HIV Agents Type of study: Prognostic_studies Limits: Adult / Humans / Male / Middle aged Language: En Journal: Clin Pharmacol Ther Year: 2002 Document type: Article Affiliation country: Country of publication:
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Oxazines / HIV Protease Inhibitors / Indinavir / Ritonavir / Anti-HIV Agents Type of study: Prognostic_studies Limits: Adult / Humans / Male / Middle aged Language: En Journal: Clin Pharmacol Ther Year: 2002 Document type: Article Affiliation country: Country of publication: